rxstat › Shortages › Lidocaine

Lidocaine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lidocaine products are in shortage in Canada (2 of 22 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 / 22
In shortage since
Jun 21, 2016
Reports on file
98
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 00884154 · since Dec 17, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 00884154 · since Dec 1, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortage
LIDODAN JELLY 2%(SINGLE USE SYRINGE)
2% · JELLY · ODAN LABORATORIES LTD
DIN 02167603 · since Jun 21, 2016, no end estimate · Disruption of the manufacture of the drug.
Anticipated
LIDOCAINE HYDROCHLORIDE INJECTION USP
20MG · SOLUTION · PFIZER CANADA ULC
DIN 00436208 · Disruption of the manufacture of the drug.
Resolved
LIDOCAINE INJECTION BP
2% · SOLUTION · EUGIA PHARMA INC.
DIN 02530457 · ended May 7, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
LIDOCAINE INJECTION BP
1% · SOLUTION · EUGIA PHARMA INC.
DIN 02530449 · ended May 7, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02422018 · ended Jan 26, 2026 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Oct 28, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2%
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00036641 · ended Oct 27, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 2%
20MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00036641 · ended Oct 9, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Lidocaine is currently affected by 2 active shortage reports filed with Health Canada by PFIZER CANADA ULC, ODAN LABORATORIES LTD.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lidocaine is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BB).

Recent changes

Common questions

When will Lidocaine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Lidocaine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiarrhythmics, class i and iii)

Widespread shortageDisopyramide1 of 1 reported products affectedWidespread shortageProcainamide4 of 5 reported products affectedPartial shortageFlecainide1 of 8 reported products affected · est. return Jul 17, 2026No current shortageAmiodaroneDiscontinuedBretylium Tosylate0 of 1 reported products affectedNo current shortageMexiletine

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.